title: Review of home phototherapy.
abstract: BACKGROUND
  Outpatient phototherapy is a safe, effective, and low-cost treatment modality for moderate to severe psoriasis. Barriers to outpatient phototherapy including patient inconvenience, patient co-pays, decreased physician compensation, and insurance disincentive structures have led to decreased use and underutilization of phototherapy. Home phototherapy can potentially overcome many of the barriers associated with outpatient treatment but is not widely used because of concerns over safety and efficacy, lack of resident and physician education, and lack of insurance coverage.
  
  
  OBJECTIVE
  The purpose of this study is to review the use of phototherapy with emphasis on the safety, efficacy, and practical use of home phototherapy.
  
  
  METHODS
  A comprehensive Pubmed literature search was done using the keywords NB-UVB, narrowband UVB, BB-UVB, broadband UVB, PUVA, psoralen and UVA, UVA, history of phototherapy, mechanism of phototherapy, phototherapy in dermatology, home phototherapy, and phototherapy for psoriasis. All relevant articles were reviewed.
  
  
  CONCLUSIONS
  Home NB-UVB phototherapy can be as safe, effective, and cost-effective as outpatient phototherapy. Further, home UVB is more convenient for patients, has higher patient satisfaction, and a lower treatment burden compared to outpatient phototherapy. Home NB-UVB should be considered as a treatment option for patients eligible for phototherapy.
authors.affiliation: Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. arajpara@gmail.com
authors.forename: Anand N
authors.initials: AN
authors.lastname: Rajpara
authors.forename: Jenna L
authors.initials: JL
authors.lastname: O'Neill
authors.forename: Bridgit V
authors.initials: BV
authors.lastname: Nolan
authors.forename: Brad A
authors.initials: BA
authors.lastname: Yentzer
authors.forename: Steve R
authors.initials: SR
authors.lastname: Feldman
mesh_terms: D000075202:Contraindications; D003363:Cost Control; D005260:Female; D006701:Home Nursing / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D009819:Office Visits / Q000191:economics; D011701:PUVA Therapy / Q000009:adverse effects / Q000191:economics / Q000706:statistics & numerical data / Q000639:trends; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000627:therapeutic use; D010789:Phototherapy / Q000009:adverse effects / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012878:Skin Neoplasms / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D017319:Photosensitizing Agents